Multiple Risk Factors in Cardiovascular Disease pp 247-254 | Cite as
Drugs Affecting HDL/Triglyceride Levels
Chapter
Abstract
Adult high density lipoprotein-cholesterol (HDL-C), and triglyceride (TG) levels are the product of numerous factors and may significantly influence cardiovascular morbidity. A general aim of pharmacological treatments is that of reducing plasma TG, as well as of increasing HDL-C levels.
Keywords
Lower Density Lipoprotein Cholesteryl Ester Transfer Protein Hepatic Lipase Cholesteryl Ester Transfer Protein Activity Gemfibrozil Treatment
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Durrington P. N. and Miller I. B. (1985): Atherosclerosis, 55: 187–194.PubMedCrossRefGoogle Scholar
- 2.Eisenberg S. (1984): J. Lipid Res., 25: 1017–1057.PubMedGoogle Scholar
- 3.Franceschini G., Montanari G., Cittella C., Colombo L. and Sirtori C. B. (1985): Metabolism, 34: 597–599.PubMedCrossRefGoogle Scholar
- 4.Franceschini G., Sirtori M., Vaccarino V., Gianfranceschi G., Chiesa G. and Sirtori C. R., (1989): J. Lab. Clin. Med., 114: 250–259.PubMedGoogle Scholar
- 5.Franceschini G., Sirtori M., Vaccarino V., et al. (1989): Arteriosclerosis, 9: 462–469.PubMedCrossRefGoogle Scholar
- 6.Franceschini G., Bernini F., Michelagnoli S. et al. (1990): Atherosclerosis, 81: 41–49.PubMedCrossRefGoogle Scholar
- 7.Friedman G., Chajek-Shaul T., Stein O. V., Noe L, Etienne J. and Stein Y. (1986): Biochim. Biophys. Acta, 877: 112–120.PubMedCrossRefGoogle Scholar
- 8.Garg A. and Grundy S. M. (1988): N. Engl. J. Med., 318: 81–86.PubMedCrossRefGoogle Scholar
- 9.Johansson J. and Carlson L. A. (1990): Atherosclerosis, 83: 207–216.PubMedCrossRefGoogle Scholar
- 10.Levy R. I., Brensike J. F., Epstein S. E., et al. (1984): Circulation, 69: 325–337.PubMedCrossRefGoogle Scholar
- 11.Luoma P. V. (1988): Pharmacol. Ther., 62: 243–249.Google Scholar
- 12.Manninen Y., Huttunen J. K., Heinonen D. P., Tenkanen L. and Frick M. H. (1989): Am. J. Cardiol., 63: 42H–47H.PubMedCrossRefGoogle Scholar
- 13.Patsch J. R, Gotto A. M. Jr, Olivecrona T., Eisenberg S. (1978): Lancet, ii: 391–392.Google Scholar
- 14.Saku K., Gartside P., Hynd B. A. and Kashyap M. L. (1985): J. Clin. Invest., 75: 1702–1712.PubMedCrossRefGoogle Scholar
- 15.Schaefer E. G., Levy R. I., Anderson D. W., Danner R. N., Brewer H. B. Jr and Blackwelder W. C. (1978): Lancet, ii: 391–392.CrossRefGoogle Scholar
- 16.Shepherd J., Packard C. J., Patsch J. R, Gotto A. M. Jr. and Taunton O. D. (1979): J. Clin. Invest., 63: 858–867.PubMedCrossRefGoogle Scholar
- 17.Sirtori C. R, Franceschini G., Gianfranceschi G., Sirtori M., Montanari G., Tremoli E., Maderna P., Colli S., Zoppi F. (1987): J. Lab. Clin. Mad., 110: 279–286.Google Scholar
- 18.Sirtori C. R and Franceschini G. (1988): Pharmacol. Ther., 37: 167–191.PubMedCrossRefGoogle Scholar
- 19.Sirtori C. R., Johnson B., Vaccarino V., et al. (1989): Clin. Pharmacol. Ther., 45: 617–626.PubMedCrossRefGoogle Scholar
- 20.Sirtori C. R., Calabresi L., Franceschini G., Gianfranceschini G., Zoppi F., Winkler S., Bilotta P. and Zampetti G. (1990): Atherosclerosis, 84: 203–211.PubMedCrossRefGoogle Scholar
- 21.Taskinen M. R. and Nikkila E. A. (1988): Atherosclerosis, 69: 249–255.PubMedCrossRefGoogle Scholar
- 22.Witztum J. L., Schonfeld G., Weidman S. W., Giese W. E. and Dillingham M. A. (1979): Metabolism, 28: 221–229.PubMedCrossRefGoogle Scholar
- 23.Yamamoto A, Matsuzawa Y., Yokoyama S., Funahashi T., Yamamura T. and Kishino B. (1986): Am. J. Cardiol., 57: 29–35.CrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media Dordrecht 1992